Evidence map›Paper›PMID 38544833›Full record

SynthesisFrontiers in oncology2024

Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.

Jing Zhang, Longchao Li, Li Zhang, Xia Zhe, Min Tang, Xiaoyan Lei, Xiaoling Zhang

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jing ZhangDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Longchao LiDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Li ZhangDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xia ZheDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Min TangDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xiaoyan LeiDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xiaoling ZhangDepartment of Magnetic Resonance Imaging (MRI), Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The objective of this study was to conduct a meta-analysis comparing the diagnostic efficacy of models based on diffusion-weighted imaging (DWI)-MRI, dynamic contrast enhancement (DCE)-MRI, and combination models (DCE and DWI) in distinguishing benign from malignant non-mass enhancement (NME) breast lesions. Materials and methods: PubMed, Embase, and Cochrane Library were searched, from inception to January 30, 2023, for studies that used DCE or DWI-MRI for the prediction of NME breast cancer patients. A bivariate random-effects model was used to calculate the meta-analytic sensitivity, specificity, and area under the curve (AUC) of the DCE, DWI, and combination models. Subgroup analysis and meta-regression analysis were performed to find the source of heterogeneity. Results: Of the 838 articles screened, 18 were eligible for analysis (13 on DCE, five on DWI, and four studies reporting the diagnostic accuracy of both DCE and DWI). The funnel plot showed no publication bias ( Conclusion: The combination model (DCE and DWI) outperformed DCE or DWI alone in identifying benign and malignant NME lesions. The DCE-CRE feature was the most specific test for ruling in NME cancers.

Indexed as

breast cancerdiffusion-weighted imagingdynamic contrast enhancementmeta-analysisnon-mass enhancement lesions

Identifiers

PMID38544833
PMCPMC10967224
OpenAlexW4392714329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.